| Code | CSB-AP002351HU |
| Abbreviation | Recombinant Human TNFSF18 protein, partial (Active) |
| MSDS | |
| Size | $142 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
TNFSF18 (GITRL) engages the GITR receptor on T cells to modulate co-stimulatory signaling relevant to tumor immunology and regulatory T-cell biology. This tag-free recombinant human TNFSF18, spanning residues 74–199, stimulates IL-8 production in human PBMCs at concentrations of 0.1–10 ng/mL, confirming potent NF-κB pathway activation suitable for cell-based functional assays, GITR-dependent T-cell co-stimulation studies, and reference standardization in cytokine detection platforms. Endotoxin levels below 1.0 EU/μg eliminate LPS-driven artifacts that would otherwise confound immune cell activation readouts, making this preparation appropriate for in vivo tumor models and antibody development workflows requiring a reliable coating antigen or positive control. Purity exceeding 98% by SDS-PAGE, combined with this stringent endotoxin control, supports use in signaling pathway dissection and proliferation assays where activity must be unambiguously attributed to GITRL engagement.
There are currently no reviews for this product.